Chikai Lai

302 Flips | 6 Magazines | 290 Likes | 1 Following | 27 Followers | @chikailai | Keep up with Chikai Lai on Flipboard, a place to see the stories, photos, and updates that matter to you. Flipboard creates a personalized magazine full of everything, from world news to life’s great moments. Download Flipboard for free and search for “Chikai Lai”

BioMarin Pharma - Orphan Pharma Model Does Not Warrant Special Valuation

<b>BioMarin Pharmaceutical</b> (NASDAQ:BMRN) is a successful biotech firm which focuses on rare diseases. The fact that the company focuses on these niche …

Profit

Why the Current Focus on Drug Prices is Misguided

Drugs are not the primary driver of health spending growth. In fact, in a perfect world, drugs and vaccines that cure and prevent all diseases should …

Drug company billionaire pulls out of Liberal cash-for-access fundraiser

The billionaire chairman of pharmaceutical giant Apotex has pulled out of an elite "cash for access" fundraiser at which Finance Minister Bill Morneau is the star attraction – two days after the Liberal Party sent a letter to cabinet announcing it plans to ban business executives or others from …

The Future of Orphan Drugs

<b>Orphan Drugs: Future opportunities and challenges</b> <b></b> The orphan drug..<b>Price: $695</b>

Administrative Law

Mylan Agrees to Pay $465 Million for Ripping Off Medicare on EpiPens, Stock Price Soars

Mylan, the drug company that makes EpiPen, has been overcharging Medicare and Medicaid for years. But today the pharmaceutical company had to finally …

Did landmark laws from Congress enable high drug prices?

WASHINGTON (AP) — Lawmakers are venting outrage over high prescription drug costs, but lawmakers and presidents of both parties may have set the …

Health Care

Home | U.S. Senator Tammy Baldwin of Wisconsin

Regional Contacts<p>Eau Claire<p>500 South Barstow Street, Suite LL2<br>Eau Claire, WI 54701-3608<br>Phone: (715) 832-8424<p>Green Bay<p>1039 West Mason, Suite 119<br>Green …

Green Bay

Price Gouging and the Dangerous New Breed of Pharma Companies

I met Tony in 2001 when he was sent to me with severe muscle weakness. Confined to a wheelchair and unable to care for himself, Tony had been told he had amyotrophic lateral sclerosis, or ALS, a fatal neurodegenerative disorder. It turned out Tony actually had Lambert-Eaton myasthenic syndrome, a …

Amgen is the latest to raise drug prices despite public outcry

Amgen Inc.’s second quarter was a solid one with promising potential: earnings and revenue met expectations, and the company increased its 2016 …

Amgen

We're all paying a high price for drug company profiteering

The drug companies are ripping us off, pill by pill, shot by shot. Instead of working to earn reasonable returns by relieving our suffering and saving lives, they now focus on profits above all. Their main targets are insurance companies. But when insurance companies take a hit, they bump up …

How Competition Can Bring Down Drug Prices

is president and CEO of , a health-care performance improvement alliance. Drug costs represent about 14% of our country’s $3 trillion annual health expenditure, and are growing rapidly. According to Health and Human Services, total drug spending increased by 12.2% last year, the highest in a …

Dow Jones

Style Guide: How to Dress for Every Wedding

The vast range in types of weddings can be daunting — beach destination, indoor ceremony / outdoor reception, Daddy-owns-the-country-club formal, …

Men's Fashion

China secures bulk drug discounts

China's National Health and Family Planning Commission (NHFPC) negotiated price discounts on three patented drugs in return for bulk purchase …

Japanese-style Star Wars jackets are the perfect combination of fashionable and geeky!

“Wear me, you will. Looking good, you will be.”<p>Fans of Star Wars and traditional Japanese clothing, your day has come! These new <i>hanten</i>, traditional …

Industry calls for new antimicrobial business models

More than 80 pharma, biotech and diagnostics companies have signed a declaration on combating antimicrobial resistance. The document, released …

Biotechnology

Pfizer hikes U.S. prices for over 100 drugs on January 1

Pfizer confirmed a 9.4% increase for heavily advertised pain drug Lyrica, which generated $2.3 billion in 2014 U.S. sales; a 12.9% increase for erectile dysfunction drug Viagra, which had 2014 U.S. sales of $1.1 billion; and a 5% increase for Ibrance, a novel breast cancer drug launched last year …

Breast Cancer

What's Up Next? Biotech And Pharma Predictions For 2016

Almost every year, I’ve tried to make some predictions about what will happen over the next 12 months in healthcare. This year, I’m going back to a format proposed by former Forbes.com editor Paul Maidment. Here are some thoughts on drug pricing, Obamacare and more.<p><b>The Big Trend</b><p>Health policy …

Sanofi's Ex-Chief Viehbacher Launches Boston Pharma With $600 Million

November 19, 2015<br>By Mark Terry, BioSpace.com Breaking News Staff<p>Cambridge, Mass.-based <b>Gurnet Point Capital</b> <b>announced</b> today that it is launching a new …

Biotech's Bad Boy Martin Shkreli Named CEO of KaloBios

November 20, 2015<br>By Alex Keown, BioSpace.com Breaking News Staff<p>SOUTH SAN FRANCISCO – A day after <b>acquiring</b> 70 percent of <b>KaloBios</b> , <b>Martin Shkreli</b>, the …

FDA approves Takeda drug for blood cancer multiple myeloma

NEW YORK (AP) — The U.S. Food and Drug Administration on Friday approved a third drug to treat multiple myeloma, a type of blood cancer.<p>The approved pill, called Ninlaro, is made by Japan's Takeda Pharmaceutical Co. The FDA approved two other multiple myeloma treatments this year, one from Johnson …

Martin Shkreli is now the CEO of a publicly traded pharmaceutical company

In a release on Thursday, KaloBios named Shkreli CEO and chairman of the board while also adding three new board members.<p>KaloBios saw its stock price rise more than 400% on Thursday after Shkreli and his associates reported that they'd purchased 70% of the company's outstanding shares earlier this …

Martin Shkreli

People don’t buy what you do; they buy why you do it. And what you do simply proves what you believe. @simonsinek http://t.co/Yzs1hoUcxf

Gilead's Blockbuster Sovaldi Linked to Slower Heartbeats and Puts Patients at Risk of Passing Out

November 5, 2015<br>By Alex Keown, BioSpace.com Breaking News Staff<p>NEW YORK – A team of French doctors reported <b>Gilead Sciences, Inc.</b> ’s blockbuster …

这个全美都讨厌的人,除了把艾滋病药价提高了55倍还做了什么?